melanoma (skin)

Showing 26 - 50 of 328

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Esophageal Cancer Trial in Toronto ([Ga-68]-PNT6555, [Lu-177]-PNT6555)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +4 more
  • Toronto, Ontario, Canada
    University Health Network - Princess Margaret Cancer Centre
Aug 16, 2022

Melanoma (Skin), Melanoma Stage IV, Melanoma, Uveal Trial in Rochester ([203Pb]VMT01, [68Ga]VMT02)

Recruiting
  • Melanoma (Skin)
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Aug 5, 2022

Melanoma (Skin), Triple-Negative Breast Cancer, NSCLC Trial (PeptiCRAd-1, Cyclophosphamide, Pembrolizumab)

Not yet recruiting
  • Melanoma (Skin)
  • +2 more
  • (no location specified)
Aug 5, 2022

Melanoma (Skin), Melanoma, Uveal Trial in Oxford (Tebentafusp)

Recruiting
  • Melanoma (Skin)
  • Melanoma, Uveal
  • Oxford, United Kingdom
    Churchill Hospital, Oxford University Hospitals NHS Trust
Jul 28, 2022

Melanoma Stage Iii, Melanoma Stage Iv, Melanoma Trial in Chapel Hill (Denosumab, Pembrolizumab, Nivolumab)

Active, not recruiting
  • Melanoma Stage Iii
  • +4 more
  • Chapel Hill, North Carolina
    UNC Lineberger Comprehensive Cancer Center
Jul 20, 2022

Melanoma (Skin), Melanoma in Situ Trial in Halifax (Aldesleukin, Saline)

Suspended
  • Melanoma (Skin)
  • Melanoma in Situ
  • Aldesleukin
  • Saline
  • Halifax, Nova Scotia, Canada
    Queen Elizabeth II Health Sciences Centre
Jul 18, 2022

Melanoma (Skin), Solid Tumor Trial in Australia, United States (PI-88)

Completed
  • Melanoma (Skin)
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Aurora, Colorado
  • +4 more
Jun 21, 2022

Melanoma (Skin) Trial (Emotional Freedom Techniques (EFT))

Not yet recruiting
  • Melanoma (Skin)
  • Emotional Freedom Techniques (EFT)
  • (no location specified)
Jun 14, 2022

Patients With Stage 0-IV Melanoma in Real Clinical Practice

Recruiting
  • Melanoma
  • +7 more
  • surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines
  • Moscow, Russian Federation
    N.N. Blokhin Russian Cancer Research Center
Jun 12, 2022

Melanoma, Melanoma (Skin), Moles Trial in Nizhny Novgorod, Moscow (Non-invasive adhesive system (patch))

Recruiting
  • Melanoma
  • +11 more
  • Non-invasive adhesive system (patch)
  • Nizhny Novgorod, Russian Federation
  • +1 more
Jun 12, 2022

Melanoma (Skin) Trial in Philadelphia (sorafenib tosylate, temozolomide)

Completed
  • Melanoma (Skin)
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jun 13, 2022

Melanoma (Skin) Trial in Worldwide (interferon alfa-2b, observation)

Active, not recruiting
  • Melanoma (Skin)
  • interferon alfa-2b
  • observation
  • Birmingham, Alabama
  • +532 more
Jun 8, 2022

Unresectable or Metastatic BRAFV600E Mutant Melanoma Patients

Recruiting
  • Melanoma (Skin)
  • +2 more
    • Evora, Portugal
      Hospital Evora
    May 30, 2022

    Melanoma (Skin), Nevus, Nevus, Spitz Trial in Moscow, Nizhny Novgorod (Mobile phone application "ProRodinki")

    Recruiting
    • Melanoma (Skin)
    • +9 more
    • Mobile phone application "ProRodinki"
    • Moscow, Russian Federation
    • +1 more
    May 29, 2022

    Melanoma (Skin) Trial in Philadelphia (89Zr-Df-IAB22M2C PET/CT)

    Enrolling by invitation
    • Melanoma (Skin)
    • 89Zr-Df-IAB22M2C PET/CT
    • Philadelphia, Pennsylvania
      Perleman Center for Advanced Medicine
    May 31, 2022

    Melanoma (Skin) Trial in Strasbourg (Nivolumab 10 MG/ML Intravenous Solution [OPDIVO], Cryotherapy, Ipilimumab Injection)

    Completed
    • Melanoma (Skin)
    • Nivolumab 10 MG/ML Intravenous Solution [OPDIVO]
    • +2 more
    • Strasbourg, France
      Clinique Dermatologique/Radiologie Interventionnelle/Urologie/Gy
    Apr 29, 2022

    Melanoma Detection in Switzerland With VECTRA

    Recruiting
    • Melanoma (Skin)
    • 3D imaging Total Body Photography Vectra® WB360
    • +3 more
    • Basel, Switzerland
      Department of Dermatology, University Hospital Basel
    Apr 11, 2022

    Electrical Impedance Spectroscopy for Early Diagnosis of Skin

    Suspended
    • Melanoma (Skin)
    • +7 more
    • Electrical Impedence Spectroscopy DermaSense
    • Thessaloniki, Greece
      Laboratory of Medical Physics, AUTH
    Apr 4, 2022

    To Assess Immunogenicity of Coronavirus Disease 2019 Vaccine in

    Recruiting
    • Breast Cancer
    • +2 more
    • COVID-19 Vaccine
    • Kansas City, Kansas
      The University of Kansas Cancer Center, Westwood Campus
    Mar 31, 2022

    Breast Carcinoma, Head Neck Cancer, Melanoma (Skin) Trial in Vandoeuvre-les-Nancy (Indocyanine green, Technetium99, Optonuclear

    Recruiting
    • Breast Carcinoma
    • +9 more
    • Indocyanine green
    • +3 more
    • Vandoeuvre-les-Nancy, France
      Institut de Cancérologie de Lorraine
    Mar 29, 2022

    Melanoma (Skin) Trial in Dijon, Thionville, Vandœuvre-lès-Nancy (Blood sampling)

    Active, not recruiting
    • Melanoma (Skin)
    • Blood sampling
    • Dijon, France
    • +3 more
    Mar 29, 2022

    Melanoma (Skin), Non-Small-Cell Lung Carcinoma Trial in Belgium, Spain, United Kingdom (GAd-PEV, MVA-PEV)

    Recruiting
    • Melanoma (Skin)
    • Non-Small-Cell Lung Carcinoma
    • GAd-PEV
    • MVA-PEV
    • Charleroi, Belgium
    • +6 more
    Feb 23, 2022

    Solid Tumor, Microsatellite Stable Colorectal Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Canada, Korea,

    Recruiting
    • Solid Tumor
    • +8 more
    • TBio-6517
    • Pembrolizumab
    • Phoenix, Arizona
    • +10 more
    Feb 21, 2022

    Melanoma (Skin) Trial in Salt Lake City (Aspirin 81 mg, Aspirin 325mg)

    Completed
    • Melanoma (Skin)
    • Aspirin 81 mg
    • Aspirin 325mg
    • Salt Lake City, Utah
      Huntsman Cancer Institute/University of Utah
    Feb 16, 2022

    Melanoma (Skin) Trial in Salt Lake City (Aspirin 81 mg, Aspirin 325mg, Placebo oral tablet)

    Completed
    • Melanoma (Skin)
    • Aspirin 81 mg
    • +2 more
    • Salt Lake City, Utah
      Huntsman Cancer Institute/University of Utah
    Feb 16, 2022